Expertise in

conditions

Irit Avivi

6 Weitzman Street,

Tel Aviv, TA, IL

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

6 Weitzman Street,

Tel Aviv, TA, IL

Overview

Irit Avivi practices in Tel Aviv, Israel. Ms. Avivi is highly rated in 22 conditions, according to our data. Her top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 204 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Female

Locations

6 Weitzman Street, Tel Aviv, TA, Israel

Other Locations

8, Ha'Aliya Street, Haifa, HA 31096, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)

Enrollment Status: Recruiting

Publish Date: October 03, 2025

Intervention Type: Drug

Study Drugs: Selinexor, Rituximab, Gemcitabine, Dexamethasone, Cisplatin

Study Phase: Phase 2/Phase 3

A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)

Enrollment Status: Completed

Publish Date: December 01, 2025

Intervention Type: Biological, Drug

Study Drugs: Axicabtagene Ciloleucel, Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders, Cyclophosphamide, Fludarabine

Study Phase: Phase 3

A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)

Enrollment Status: Active_not_recruiting

Publish Date: March 18, 2025

Intervention Type: Drug

Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib

Study Phase: Phase 3

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients- a Randomized, Placebo Controlled Phase II Trial DEFENCE (DEnosumab For the rEductioN of the Smoldering Myeloma transformatioN inCidence ratE)

Enrollment Status: Completed

Publish Date: February 11, 2025

Intervention Type: Drug

Study Drug: Denosumab

Study Phase: Phase 2

DREAMM 7: A Multicenter, Open-Label, Randomized Phase III Study to Evaluate the Efficacy and Safety of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (B-Vd) Compared With the Combination of Daratumumab, Bortezomib and Dexamethasone (D-Vd) in Participants With Relapsed/Refractory Multiple Myeloma

Enrollment Status: Active_not_recruiting

Publish Date: October 24, 2024

Intervention Type: Drug

Study Drugs: Belantamab Mafodotin, Daratumumab, Bortezomib, Dexamethasone

Study Phase: Phase 3

View 4 Less Clinical Trials

204 Total Publications

Unmasking the invisible: CAR T-cell therapy for intravascular large B-cell lymphoma.

Journal: Haematologica

Published: February 20, 2026

View All 204 Publications

Frequently Asked Questions about Irit Avivi

Is Irit Avivi a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Irit Avivi is classified as an Elite expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Irit Avivi participate in research or clinical trials?

Yes. Irit Avivi has published 204 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Irit Avivi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Avivi's expertise for a condition

ConditionClose